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The immediate-early (IE) genes of murine cytomegalovirus (MCMV) are expressed in the absence of prior
viral protein synthesis and regulate the transcription ofMCMV early genes. The effect ofMCMV IE genes on
growth induction was studied. Different plasmids containing MCMV IE genes were microinjected into arrested
NIH 3T3 mouse fibroblasts. Plasmids containing the iel gene coding for the 89,000-M, major IE protein pp89
were found to stimulate the expression of the c-fos protooncogene. Synthesis of pp89 and its transport to the
nucleus appeared to be required for c-fos expression. DNA synthesis occurred in cells that were injected with
MCMV IE genes and in neighboring cells that were not injected. The results suggest that the phosphoprotein
pp89 stimulates cells to enter the cell cycle.
Cytomegaloviruses (CMVs) can establish productive cy-
tolytic as well as nonproductive latent infections in cells, and
reactivation from latency to productive infection can occur.
Certain observations indicate an interdependence between
CMV replication and phase transitions of the cell cycle.
Murine CMV (MCMV) replication is dependent on the
physiological state of the cell, and the virus requires events
associated with the host S phase for initiation of viral DNA
synthesis (23). The virus itself, however, can promote cel-
lular conditions favorable for viral replication by stimulating
cells to synthesize cellular DNA (31) and to release a growth
factor (10). These results suggest that at least one CMV gene
should have an effect on the cellular genes that control the
cell cycle. Given that the expression of this gene is subject to
the control of cellular factors, this gene could play a role in
the regulation of productive and nonproductive infection of
cells.
Gene expression in MCMV is regulated in a cascade
fashion and can be subdivided into three phases, immediate-
early (IE), early (E), and late. Because stimulation of cellular
DNA synthesis and release of cellular growth factors do not
require CMV DNA synthesis (10, 31), viral functions ex-
pressed IE or E after infection should be involved. We
studied the IE genes of MCMV as candidates. The IE genes
ofMCMV are clustered in a region of about 10 kilobase pairs
(13). Three IE transcription units are contained in this
region, iel, ie2, and ie3 (14). The gene ieI in transcription
unit iel and genes transcribed from ie3 use the same pro-
moter which is controlled by a very long and complex
enhancer located upstream (5, 15). The promoter of the
transcription unit ie2 at a position downstream of the en-
hancer is also regulated by this sequence. MCMV and the
human CMV have similar enhancer sequences (2), and
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several cellular factors bind to different sequence motifs and
thus regulate the expression of the IE genes (9).
CMV IE gene products play a role in the transcriptional
activation ofCMV E genes. Among the MCMV IE genes, ieI
is most abundantly expressed and gives rise to the nonvirion
phosphoprotein pp89, the major IE protein (16). pp89 acti-
vates gene in trans without apparent promoter specificity
(18). To exert its function in gene regulation, pp89 should
directly or indirectly interact with DNA. Direct binding to
DNA has not yet been demonstrated, but binding to histones
has been reported (24a). As with viral proteins of other
viruses that influence cell cycle regulation (11, 27, 29), an
association of pp89 with kinase activity has recently been
shown (A. Barnekow, J. Schickedanz, and U. H. Koszi-
nowski, manuscript in preparation). These multifunctional
properties of pp89 have led us to assume that it plays a role
in cell cycle regulation. To investigate this possibility, we
looked for stimulation of cellular DNA synthesis by pp89.
To monitor the effect of the ieI gene product on cell cycle
regulation, we studied the expression of the protooncogene
c-fos. The characteristics of c-fos expression in various cell
types have led to the suggestion that it has a role in the
control of cellular growth and differentiation. Appropriate
expression of c-fos appears to be a prerequisite for the
reentry of quiescent cells into the cell cycle (25). The
expression of c-fos is rapidly induced within minutes during
the transition from the Go to the G1 phase (3, 34), and both
protein and mRNA have very short half-lives (19, 24). The
effect of the iel gene product on cell cycle regulation was
studied by microinjection of IE genes. The results suggest
that the nonstructural regulatory protein pp89 of MCMV
stimulates c-fos expression and triggers cell cycle activation.
MATERIALS AND METHODS
Cell culture. NIH 3T3 mouse fibroblasts, clone 7 (orig-
inally from D. Lowy, National Institutes of Health, Be-
thesda, Md.), were seeded onto cover slips (10 by 10 mm)
with prescratched squares and grown in Dulbecco modified
Eagle medium supplemented with 10% fetal bovine serum in
7% CO2. To arrest the cells in the subconfluent state,
medium was changed after 24 h to Dulbecco modified Eagle
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medium containing 2.5% bovine platelet-poor plasma. Cells
were injected after an arrest of 3 days.
Plasmid DNA. Cloning of MCMV DNA fragments and
plasmids pAMB25, pIE111, and pIE100 have been described
before (7, 13, 17, 18). Plasmid DNA was prepared by the
method of Holmes and Quigley (12). Restriction enzyme
digestion, agarose gel electrophoresis, and ethanol precipi-
tation of DNA were performed by standard methods (21).
Microinjection. Linearized plasmid DNA was suspended
in sterile water at concentrations of 50 ng/ml. In selected
experiments sterile filtered fluorescein isothiocyanate
(FITC)-labeled dextran (FD-150; Sigma Chemical Co.,
Munich, Federal Republic of Germany) was coinjected at
concentrations of 1.5%. The probes were centrifuged for 15
min at 20,000 x g. To ensure physiological pH conditions,
the cell medium was adjusted with HEPES (N-2-hydrox-
yethylpiperazine-N'-2-ethanesulfonic acid) to 1 mM just
before injection. Microinjection was performed with an
injection system (developed by Ansorge [1]). Injection cap-
illaries were pulled with an automatic puller (Mechanex,
Geneva, Switzerland). In individual squares of the cover
slip, the nuclei of about 15 cells were injected with .10-11
ml of solution. In each experiment 200 to 300 cells were
usually injected during 20 to 30 min. After injection the cells
were incubated in 7% CO2 for different periods of time.
Immunofluorescence. (i) Detection of MCMV IE proteins.
Cells were fixed with 3% paraformaldehyde in phosphate-
buffered saline and treated with 0.2% Triton X-100 in phos-
phate-buffered saline at 20°C. The cells were then incubated
at 37°C with the murine monoclonal antibody 6/56/6 specific
for MCMV IE protein pp89 (16). In the second step cells
were incubated at 37°C with rhodamine-labeled rabbit anti-
mouse immunoglobulin G (Dakopatts, Hamburg, Federal
Republic of Germany). For a control, nuclei of cells were
stained by incubation for 20 min with 5 jig of bisbenzimide(Hoechst 33342; Hoechst-Roussel Pharmaceuticals Inc.,
Somerville, N.J.) per ml. Cover slips were mounted on slides
and fluorescence was visualized on an inverted light micro-
scope (Zeiss) at 495 nm (FITC), 554 nm (rhodamine), or 365
nm (bisbenzimide).
(ii) Detection of c-fos antigen. Cells were fixed and permea-
bilized as described above. The c-fos antigen was detected
by polyclonal rabbit anti-fos serum, and rhodamine-labeled
swine anti-rabbit immunoglobulin served as a second anti-
body.
DNA synthesis assay. To test the stimulation of cellular
DNA synthesis, cells were arrested at the Go phase as
described above. After plasmid DNA injection, 1 ,uCi of [3H]
thymidine per ml was added, and cells were incubated at
37°C in 7% CO2 for different periods of time. After fixation of
the cells, indirect immunofluorescence, and bisbenzimide
staining, the mounted cover slips were covered with autora-
diographic stripping film (AR 10; Eastman Kodak Co.,
Rochester, N.Y.). After exposure for 2 to 3 days at room
temperature, the films were developed and fixed. [3H]thymi-
dine incorporation was visualized by black silver grains and
photographed under a microscope.
RESULTS
Expression of MCMV IE genes in mouse NIH 3T3 fibro-
blasts after microinjection. For the analysis of regulatory
effects of isolated viral genes and their products on cellular
functions, microinjection offers some advantages. First, the
cells injected with DNA can be identified by coinjection of a
fluorescence marker. This allowed us to find again each
individual injected cell. Second, the temporal relation be-
tween gene uptake and expression can be determined, as can
the number of injected cells that express the gene. Third, the
regulatory effects on cellular genes by injected viral genes
can be studied, and discrimination between direct effects on
injected cells and indirect effects on surrounding cells is
possible.
The correct expression of injected MCMV IE genes was
tested in growing subconfluent mouse NIH 3T3 fibroblasts
by using linearized plasmids containing various regions of
the MCMV IE gene region (Fig. 1). FITC-labeled dextran
was coinjected to locate the injected cells. Expression of the
IE protein pp89 was monitored for 20 h after injection by
using a monoclonal antibody specific for pp89 and a rho-
damine-labeled second antibody for detection by immuno-
fluorescence. As indicated by the number of FITC-positive
cells and the ratio between FITC- and rhodamine-positive
cells, about 70% of injected cells survived the injection
procedure, and approximately 80% of survivors expressed
pp89. Microinjection of all constructs containing the tran-
scription until iel resulted in expression of pp89. Control
injections with plasmids linearized by HindIII, which
cleaves within the fourth exon of the pp89-coding sequence,
or injection with the vector pSP62 did not reveal any
rhodamine fluorescence.
Subceliular distribution of pp89 after microinjection of the
iel gene in arrested mouse NIH 3T3 fibroblasts. Expression of
the c-fos gene as well as DNA synthesis was low or absent in
resting cells. To study the stimulation of the cell cycle
following microinjection of MCMV IE genes, NIH 3T3 cells
were synchronized in the Go phase of the cell cycle by
preincubation for 3 days with medium containing 2.5%
platelet-poor plasma. Platelet-poor plasma is depleted of
platelet-derived growth factor, which is necessary for NIH
3T3 cell proliferation, but possesses all other components
that are required (35). This protocol resulted in about 95% of
cells being arrested in the Go phase, as demonstrated by a
lack of [3H]thymidine incorporation into the nucleus during
a 24-h incubation period. After the addition of 20% fetal
bovine serum for 24 h, incorporation of [3H]thymidine in
about 90% of cell nuclei confirmed that the cells could be
released from growth arrest.
In contrast to growing cells, only approximately 20% of
arrested cells survived after injection, but similar to growing
cells, 80% of these expressed pp89 20 h later. It was
postulated that prior to any effect on cellular gene functions,
the ieI gene product had to arrive at the nucleus. During
permissive infection with MCMV, the ieI gene is the first
viral gene that is expressed. The protein is already synthe-
sized in the first 2 h of infection, and the antigen can be
detected by immunofluorescence at about the same time in
the nucleus but not in the cytoplasm of infected cells. The
protein is stable and resides in the nucleus throughout the
replication period (13, 16). We examined the kinetics of pp89
antigen expression and the nuclear transport of the antigen
following microinjection of the ieI gene into quiescent cells.
Surprisingly, the kinetics of subcellular distribution of pp89
antigen was different between infection by virus and micro-
injection of the gene (Fig. 2). Four hours following injection
of ieI (Fig. 2b) and also 8 h postinjection (data not shown),
pp89 antigen was mainly located in the cytoplasm, whereas
only as late as 12 h after microinjection the majority of the
antigen appeared to be located in the nucleus (Fig. 2d). An
exclusive nuclear localization of pp89 antigen was seen at 24
h (Fig. 2f) and 30 h after microinjection (data not shown).
MCMV pp89 stimulates c-fos antigen expression. The c-fos
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FIG. 1. Physical map ofMCMV IE genes. (a) HindIII cleavage sites. (b) Organization of the IE region. The locations of the transcription
units iel, ie2, and ie3; the direction of transcription; and the structure of the major RNA transcribed from the ieI gene are indicated. The open
reading frame is indicated as a segmented solid bar, and the promoter regulatory enhancer region is indicated as a hatched box. The structural
organizations of ie2 and ie3 are not precisely known; therefore, they are symbolized by open arrows. (c) Plasmid-cloned DNA fragments of
the MCMV IE region used for microinjection. kbp, Kilobase pairs.
protooncogene product is present in low amounts in normal
cells, and its expression is induced rapidly during cell growth
and proliferation (3). Expression of c-fos was monitored at
different times after injection of the iel gene by immunoflu-
orescence (Fig. 3). We reasoned that different than other
stimuli which rapidly turn on c-fos expression, any effect of
ieI gene injection that was associated with the function of
pp89 should be delayed. Because pp89 remains in the
cytoplasm during the first 4 h postinjection of DNA, c-fos
expression should be turned on later. No c-fos expression
was detectable in the nuclei of injected cells after 1 h (Fig.
3b) or 2 and 4 h postinjection (data not shown), whereas at 20
h postinjection, at times when pp89 was found predomi-
nantly in the nucleus, a distinct c-fos expression was also
observed in the nuclei of injected cells (Fig. 3d). On the other
hand, c-fos expression was already seen after 1 h following
stimulation of the cells with 20% fetal bovine serum (Fig.
3e).
Linearization of plasmids containing the ieI gene by
HindlIl cleavage with cuts within the fourth exon encoding
pp89 (Fig. 1) abolished trans-activation (17). Similarly, no
effect on c-fos expression was seen after injection of plas-
mids that were linearized with HindlIl (data not shown).
After microinjection with the intact ieI gene, expression of
c-fos was seen in 90% of FITC-positive cells; this was
comparable to the number of cells that expressed pp89. No
c-fos expression was detected in noninjected neighboring
cells. After microinjection of the vector plasmid pSP62, c-fos
expression was not detectable during the 20-h incubation
period (data not shown), excluding nonspecific effects of
irrelevant DNA on c-fos expression. These data suggest that
stimulation of c-fos expression by the MCMV ieI gene
requires synthesis of pp89 and its transport to the nucleus.
Stimulation of DNA synthesis in quiescent cells after micro-
injection of the ieI gene. To study whether the growth arrest
in quiescent cells is released by pp89, cells were labeled with
[3H]thymidine after injection of the ieI gene. At different
times postinjection, incorporation of the radioactive nucleo-
tide was examined by autoradiography. As described above,
about 80% of cells that survived the injection expressed
pp89. After 4 to 12 h no enhanced DNA synthesis was
observed (Table 1 and Fig. 4b), whereas 24 h after injection
a significant stimulation of DNA synthesis was seen (Table 1
and Fig. 4d). Note that different than c-fos expression, there
was no stringent correlation between expression of pp89 and
DNA synthesis. In some experiments, [3H]thymidine incor-
poration also occurred in noninjected surrounding cells. This
could result in a higher number of cells with labeled nuclei
than of cells that express pp89. Results of a typical experi-
ment in which such conditions were observed are repre-
sented in Table 1. Conversely, few individual cells were seen
that expressed pp89 but that were not active in DNA
synthesis (data not shown). Nevertheless, stimulation of
DNA synthesis was dependent on the injection and expres-
sion of the iel gene, since after injection with plasmid
linearized by Hindlll cleavage or injection with the vector
pSP62 DNA for control, there was no induction of DNA
synthesis (Table 1), and DNA synthesis in the noninjected
control areas remained as low as expected for arrested cells.
Further experiments were carried out to detect a putative
additional effect of the other two IE transcription units of
MCMV, ie2 and ie3. The data are summarized in Table 2.
The ieI gene was again sufficient for the induction of DNA
synthesis, and there was no evidence that the presence of ie2
or ie3 sequences improved the degree of stimulation.
DISCUSSION
Stimulation of cellular DNA synthesis by CMV (31)
caused by the release of a growth factor by permissive and
nonpermissive cells infected with CMV (10) demonstrated
the effect of CMV infection on cell cycle regulation. Since
viral DNA synthesis is not required for induction of host cell
DNA synthesis (4), the effect is either due to a viral
structural protein transferred by infection or viral gene
functions expressed during the IE or E phase of infection.
The MCMV ieI gene product pp89 appeared to be a likely








 at Universitaetsbibliothek M
uenchen on O






3344 SCHICKEDANZ ET AL.
I
._ . . .
__--A m..............................................
FIG. 2. Immunocytological localization of viral pp89 at various times after injection of the iel gene. The composite of micrographs shows
pairs of identical sections of NIH 3T3 fibroblast cell monolayers. Cells are stained either directly with FITC-labeled dextran to indicate
injected cells (a, c, and e) or indirectly with monoclonal antibody to pp89 and rhodamine-labeled second antibody to indicate expression of
the injected gene (b, d, and f). Growth-arrested cells were coinjected with FITC and plasmid pIE100 DNA; and indirect immunofluorescence
was carried out 4 h (a and b), 12 h (c and d), and 24 h (e and f) later. FITC is located in the nucleus, whereas pp89 is located in the cytoplasm
at 4 h, in the cytoplasm and nucleus at 12 h, and selectively in the nucleus 24 h after injection of the ieI gene. Magnification, X400.
regulation, because this protein is located in the nucleus of
infected cells (16), binds to histones (24a), is associated with
a kinase activity (Barnekow et al., in preparation), and acts
as a transcriptional regulator (18). We chose to study c-fos
expression as an indicator gene involved in the early steps of
cell cycle regulation. Because the expression of c-fos does
not necessarily result in the transition of cells into the S
phase of the cell cycle (20), cellular DNA synthesis was also
tested. The results indicate that the MCMV ieI gene product
pp89 stimulates cells to enter the cell cycle and that c-fos
induction by pp89 is part of the cell cycle activation path-
way.
Results of our experiments demonstrate that the c-fos
protein is accumulated after injection of the MCMV ieI gene
DNA into quiescent NIH 3T3 cells. For two reasons, the
increased c-fos expression is not due to mechanical irritation
of cells during injection or to nonspecific effects of plasmid
DNA. First, c-fos protein and mRNA have very short
half-lives (19, 24); for example, c-fos protein accumulation
following wounding of NIH 3T3 cells has been demonstrated
to occur within 1 h, to remain high for another 1 h, and then
gradually to decrease within 3 h to barely detectable levels
(34). This kinetics of c-fos expression differs from that
following injection of the MCMV ieI gene. Second, injection
of the ieI gene linearized within the coding region or of
vector DNA did not lead to the accumulation of c-fos.
The induction of c-fos was delayed after microinjection of
the iel gene, and c-fos was detected at 20 h but not during the
first 4 h. We suggest that the delayed c-fos accumulation is
caused by the delayed appearance of pp89 in the nucleus.
Although pp89 is synthesized after gene injection, it remains
located exclusively in the cytoplasm during the first 4 h, and
it probably cannot act as a trans-activator during this period.
As yet there is no explanation for the difference between
nuclear transport after virus infection and injection of the
gene. Additional MCMV proteins probably do not play a role
in the nuclear transport of pp89, because in cells that stably
express the transfected ieI gene (17), pp89 is detected
selectively in the nucleus.
Delayed induction of c-fos by a viral regulatory protein is,
however, not unique for pp89. Polyomavirus can also cause
a delayed and sustained accumulation of c-fos mRNA be-
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FIG. 3. Induction of the c-fos protein by viral pp89 at various times after ieI gene injection. The composite of micrographs shows c-fos
antigen expression in NIH 3T3 fibroblast cell monolayers. Growth-arrested cells were coinjected with FITC and plasmid pIE100 DNA, and
indirect immunofluorescence with antiserum to c-fos and rhodamine-labeled second antibody was carried out 1 h (a and b) and 20 h (c and
d) later. FITC fluorescence is seen as an injection marker in panels a and c, and immunofluorescence to detect c-fos antigen expression is
shown in panels b and d. The micrographs in panels e and f show c-fos antigen 1 h after stimulation with 20% fetal bovine serum (e) and no
c-fos in cells without stimulation (f). Magnification, x400.
TABLE 1. Relationship between pp89 expression and DNA synthesis in arrested NIH 3T3 fibroblasts after microinjection of DNA
Labeling No. of No. of No. of No. of cellsProbe injecteda time (h) injected FITC-positive pp89-positive with DNA
cells cells cells synthesisb
pIE100 4 342 80 61 0
8 310 61 54 0
12 304 123 74 0
24 321 40 35 50
pSP62 24 350 70 0 5
pIE100-HindIIIc 24 157 NDd 0 3
a Results are of one representative experiment.
b The total number of cells with silver grains was determined in areas containing injected cells. From this value, the basal DNA synthesis activity was subtracted
and evaluated by counting the number of positive cells in a noninjected area with a comparable number of cells.
c The plasmid was linearized by HindIII cleavage to interrupt the coding region of the iel gene.
d ND, No coinjection by FITC.
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FIG. 4. DNA replication in cells injected with plasmid pIE100 DNA. The composite of micrographs shows either identical sections of cells
stained with bisbenzimide (a and c) or autoradiography of [3H]thymidine incorporated into NIH 3T3 cells (b and d). After DNA injection cell
monolayers were incubated with [3H]thymidine for 4 h (b) or 24 h (d). Because of the high number of grains, only those nuclei that did not
synthesize DNA were detectable by bisbenzimide staining. Magnification, x250.
tween 12 and 36 h after infection which was identified as a
tumor antigen function (36). pp89 neither immortalizes nor
transforms cells, which is different than the functions of the
tumor antigens of polyomavirus or simian virus 40 and the
products of the ElA region of adenovirus that all stimulate
the cell cycle and that are involved in cell transformation (6,
8, 22, 26, 32, 33, 36). Whether this is a qualitative or merely
a quantitative difference between pp89 and the early proteins
of DNA tumor viruses is not yet clear. Transient c-fos
expression appears not to be sufficient to induce cell trans-
formation, and only when c-fos mRNA and protein are
TABLE 2. Induction of DNA synthesis in arrested NIH 3T3
fibroblasts after injection of MCMV IE genes
Probe injected Labeling No. of w%th DllsA StimulationProbinjcted time (h) experiments wynthesiNA factorb'
pIE100 4 2 1 0.1
12 5 13 1.4
18 5 6 0.7
24 9 63 7.0'
30 2 44 4.9'
pAMB25 24 2 62 6.9C
pIE111 24 3 77 8.6'
pSP62 24 7 9 1.0
pIElOO-HindIII 24 3 12 1.5
FITC 24 5 7 0.8
The percentage of cells with DNA replication is represented by the ratio
between the number of cells with nuclei containing silver grains and the
number of microinjected cells (represented by FITC-positive nuclei) x 100.
Values are the averages of independent experiments.
b Number of fold compared with DNA synthesis after injection of pSP62
DNA.
c The number of nuclei with silver grains 24 h following iel gene injection
was significantly higher than the number of nuclei with silver grains after
injection of pSP62 DNA (P < a = 0.1), as calculated by the exact rank sum
test (Wilcoxon-Mann-Whitney test).
expressed constitutively in fibroblasts do the cells become
morphologically transformed (24). Although cells that con-
stitutively express the ieI gene after transfection (17) do not
form colonies in agarose medium (unpublished data), this
does not necessarily indicate a qualitative difference, be-
cause the expression of the transformed phenotype after
transfection of the simian virus 40 early gene is also depen-
dent on the amount of large tumor antigen in cells (28).
Similar to the results of microinjection of DNA tumor
virus genes (30) and gene products (33), replicative cellular
DNA synthesis could be induced by the ieI gene. Mere DNA
repair synthesis caused by the damage inflicted on cells by
the injection procedure was considered unlikely, because
DNA synthesis (i) required the injection of a functional ieI
gene, (ii) was not seen before 24 h, and (iii) was not restricted
to injected cells. There is clear evidence that early proteins
of DNA tumor viruses cause cells to release growth factors
(26). The evidence for induction of growth factor production
following ieI gene expression is only indirect and was
concluded from the observation that in some experiments a
variable percentage of cells surrounding the microinjected
cell incorporated [3H]thymidine. The amount of growth
factor production was certainly very low, because, although
cells that expressed pp89 accumulated c-fos, some cells were
detectable that expressed pp89 but that were not active in
cellular DNA synthesis. Attempts to demonstrate growth
factor activity in conditioned media of cells that express the
transfected ieI gene have failed so far.
Induction of cell proliferation probably plays a role in the
productive lytic pathway of MCMV replication. Muller and
Hudson (23) have described that, in contrast to asynchro-
nous cells, which produce viral progeny within the first 12 h
postinfection, after infection of cells arrested early in the G1
phase, replication of viral DNA begins first after 16 to 20 h
postinfection and reaches a maximum between 20 and 24 h
postinfection. The iel gene is the first viral gene that is
expressed after infection. The ability of the ieI gene product
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to stimulate cells to proliferate supports viral replication. The
release of growth factors would stimulate surrounding cells to
become target cells for secondary infection. Whether the
success or the failure to induce the cell cycle could also play
a role in the maintenance of viral latency and the reactivation
to productive infection is a matter of speculation.
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